ROTHBLATT MARTINE A

PrivateCIK: 1106578

ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market

Open‑market sale worth $4.86M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 5 sales
InsiderROTHBLATT MARTINE ACIK 1106578
IssuerUNITED THERAPEUTICS CORPCIK 1082554
DirectorOfficer· Chairperson & CEO
Since Mar 2026
-9.50K
Net shares
Net seller
$4.86M
Total sold
5
Open market trades
0B · 5S
7
Total transactions
9.50K acquired · 19K disposed
Non-Derivative Transactions6

Common Stock

Indirect
M · Option Exercise

Shares

+9.50K

Price / share

$135.42

Trade value

$1.29M

% of position

2.9%
8/24/2026
324.44K333.94K

Common Stock

Indirect
S · Sale

Shares

224.00

Price / share

$509.41

Trade value

$114.11K

% of position

0.1%
8/24/2026
333.94K333.72K

Common Stock

Indirect
S · Sale

Shares

1.32K

Price / share

$510.52

Trade value

$675.42K

% of position

0.4%
8/24/2026
333.72K332.40K

Common Stock

Indirect
S · Sale

Shares

3.06K

Price / share

$511.63

Trade value

$1.56M

% of position

0.9%
8/24/2026
332.40K329.34K

Common Stock

Indirect
S · Sale

Shares

3.59K

Price / share

$512.46

Trade value

$1.84M

% of position

1.1%
8/24/2026
329.34K325.75K

Common Stock

Indirect
S · Sale

Shares

1.30K

Price / share

$513.35

Trade value

$669.92K

% of position

0.4%
8/24/2026
325.75K324.44K
Total

Net shares

+0.00

Net value

-$3.58M

Derivative Transactions1

Stock Option

Indirect
M · Option Exercise
Converts to

Common Stock

9.50K shares

Shares

9.50K

Strike price

135.42

Held after

75.41K

Exercisable

8/24/2026
Non-Derivative Holdings (Post-Transaction)5

Common Stock

Indirect
Shares owned166.00

Common Stock

Direct
Shares owned40.51K

Common Stock

Indirect
Shares owned45.60K

Common Stock

Indirect
Shares owned249.11K

Common Stock

Indirect
Shares owned8.90K
Total
40.51K direct·303.77K indirect344.29K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported